Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer

Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States. However, reliable diagnostic or prognostic tumor markers have not been identified for endometrial cancer. In this study, we examined whether urokinase plasminogen activator receptor (UPAR), a glycosyl-phosphat...

Descripció completa

Dades bibliogràfiques

Publicat a:	Proc Natl Acad Sci U S A
Autors principals:	Memarzadeh, Sanaz, Kozak, Katherine R., Chang, Lisbeth, Natarajan, Sathima, Shintaku, Peter, Reddy, Srinivasa T., Farias-Eisner, Robin
Format:	Artigo
Idioma:	Inglês
Publicat:	National Academy of Sciences 2002
Matèries:	Biological Sciences
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC125001/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12130664/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.152127499
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!